Allergen products development for immunotherapy and allergy diagnosis in moderate to low-sized study populations - Scientific guideline

This document provides guidance on the clinical development  for allergen products for immunotherapy and allergy diagnosis in moderate to low-sized study populations.

Keywords: Allergen, allergy, allergen immunotherapy, immune therapy, small population

Draft version

Draft guideline on allergen products development for immunotherapy and allergy diagnosis in moderate to low-sized study populations

Draft: consultation closedConsultation dates: 28/02/2024 to 31/05/2024Reference Number: EMA/CHMP/72790/2024